Phase I Double-blind, Placebo-controlled Study of AZD7442

Trial Identifier:	D8850C00005
Sponsor:	AstraZeneca
NCTID::	NCT04896541
Start Date:	March 2021
Primary Completion Date:	June 2022
Study Completion Date:	June 2022
Condition:	COVID-19 Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version
	Japanese Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
JP	Fukuoka-shi, JP, 812-0025

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.